## **Trustees' Annual Report for the period** 

Period start date Period end date Day Month Year Day Month Year A **From** 6 APRIL 2023 **To** 5 APRIL 2024 Section A                        Reference and administration details **Charity name** THE MYWALIT FOUNDATION **Other names charity is known by Registered charity number (if any)** 1173973 ~~———~~ **Charity's principal address** 107 Fore Street HERTFORD **Postcode SG14 1AS** ~~————~~ **Names of the charity trustees who manage the charity Dates acted if not for whole Name of person (or body) entitled Trustee name Office (if any) year to appoint trustee (if any)** 1 THOMAS IRVING 2[KARL ] ENEVOLDSON 3[CHRISTOPHER ] HOWELL 4 ~~———~~ 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 

## Section A                        Reference and administration details 

**Names of the trustees for the charity, if any, (for example, any custodian trustees)** 

**Name Dates acted if not for whole year** ~~—_———————~~ 

March **2012** 

**TAR** 

1 



## **Names and addresses of advisers (Optional information)** 

**Type of adviser Name Address** 

## **Name of chief executive or names of senior staff members (Optional information)** 

## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

TRUST Type of governing document (eg. trust deed, constitution) CIO- FOUNDATION How the charity is constituted 

- (eg. trust, association, company) 

APPOINTED ANNUALLY AT AGM Trustee selection methods 

- (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

**Summary of the objects of the charity set out in its governing document** 

March **2012** 

**TAR** 

2 



**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

**Additional details of objectives and activities (Optional information)** 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

March **2012** 

**TAR** 

3 



Section D                      Achievements and performance 

**Summary of the main achievements of the charity during the year** 

The foundation made the following donations during the year: 09/10/20 £800.0 Overse 23 The Pelorus Fundation 0 as KENYA 09/10/20 £1,000. Overse 23 Pump Aid 00 as MALAWI 22/11/20 £2,500. Overse 23 Medical Aid for Palestinians 00 as PALESTINE 30/11/20 Palestine Children's Relief £2,500. Overse 23 Fund 00 as GAZA 

March **2012** 

**TAR** 

4 



**Section E                    Financial review Brief statement of the charity’s policy on reserves Details of any funds materially** N/A **in deficit** ~~_—_~~ **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: 

- You **may choose** to include additional information, where relevant about: • the charity’s principal sources of funds (including any fundraising); 

- • how expenditure has supported the key objectives of the charity; 

- • investment policy and objectives including any ethical investment policy adopted. 

- **Section F                     Other optional information** ~~_~~ 

- **Section G                    Declaration** 

- ~~___~~ **The trustees declare that they have approved the trustees’ report above. Signed on behalf of the charity’s trustees Signature(s) Full name(s)** THOMAS IRVING 

- **Position (eg Secretary, Chair,** CHAIR **etc)** 

- **Date** 30/09/2024 

March **2012** 

**TAR** 

5 



||**THE MYWALIT FOUNDATION**<br>**1173973**<br>**CC16a**<br>**Receipts andpayments accounts**<br>**For the period**<br>**from**<br>**06/04/2023**<br>**To**<br>**05/04/2024**<br>~~———~~|**THE MYWALIT FOUNDATION**<br>**1173973**<br>**CC16a**<br>**Receipts andpayments accounts**<br>**For the period**<br>**from**<br>**06/04/2023**<br>**To**<br>**05/04/2024**<br>~~———~~|
|---|---|---|
|**Section A Receipts and payments**|||
||**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds**<br>**Last year**||
||**to the nearest      £**<br>**to the nearest £**<br>**to the nearest £**<br>**to the nearest £**<br>**to the nearest £**||
|**A1 Receipts**|||
|DIVIDENDS<br>DONATIONS<br>**_Sub total_**_(Gross income for_<br>_AR)_<br>~~=~~|**2,082**<br>**-**<br>**-**<br>**2,082**<br>**1,897**<br>**-**<br>**-**<br>**-**<br>**-**<br>**4,500**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>_(Gross income for_<br>_AR)_**2,082**<br>**-**<br>**-**<br>**2,082**<br>**6,397**<br>~~=--_—~~||
|**A2 Asset and investment sales.**|||
|**INVESTMENTS**|**579**<br>**-**<br>**-**<br>**579**<br>**-**||
||**-**<br>**-**<br>**-**<br>**-**<br>**-**||
|**_Sub total_**|**_Sub total_                          579**<br>**-**<br>**-**<br>**579**<br>**-**||
||||
|**_Total receipts_                    2,661**<br>**-**<br>**-**<br>**2,661**<br>**6,397**<br>**A3 Payments**<br>DONATIONS<br>**6,800**<br>**-**<br>**-**<br>**6,800**<br>**7,600**<br>CHARGES<br>**939**<br>**-**<br>**-**<br>**939**<br>**985**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                        7,739**<br>**-**<br>**-**<br>**7,739**<br>**8,585**<br>**A4 Asset and investment**<br>**purchases**<br>**Investments- unrestricted funds**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total payments_**<br>**7,739**<br>**-**<br>**-**<br>**7,739**<br>**8,585**<br>**_Net of receipts/(payments)_**<br>**-                  5,078**<br>**-**<br>**-   -                  5,078**<br>**-                 2,188**<br>**A5 Transfers between funds**<br>**-**<br>**-                            -**<br>**-**<br>**-**<br>**A6 Cash funds last year end**<br>**17,794**<br>**-                            -**<br>**17,794**<br>**19,982**<br>**_Cash funds this year end_**<br>**12,716**<br>**-**<br>**-                    12,716**<br>**17,794**<br>~~===.=~~<br>~~—=====~~<br>~~===~~||**-                 2,188**<br>**-**<br>**19,982**<br>**17,794**|



CCXX R1 accounts (SS) 

08/01/2025 

1 



|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|||
|---|---|---|---|---|
|||**Unrestricted**<br>**Restricted**||**Endowment**|
|**Categories**|**Details**|**funds**<br>**funds**||**funds**|
|||**to nearest £**<br>**to nearest £**||**to nearest £**|
|**B1 Cash funds**|**9,493**<br>**-**<br>**3,223**<br>**-**<br>**-**<br>**-**<br>**-**<br>**12,716**<br>**-**<br>**-**<br>BARCLAYS<br>CAZENOVE CAPITAL<br>**_Total cash funds_**<br>~~—====>~~||||
||(agree balances with receipts and payments|(agree balances with receipts and payments|||
||account(s))|OK<br>OK||OK|
|||**Unrestricted**<br>**Restricted**||**Endowment**|
|||**funds**<br>**funds**||**funds**|
||**Details**|**to nearest £**<br>**to nearest £**||**to nearest £**|
|**B2 Other monetary assets**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~—_—~~||||
|**B3 Investment assets**|**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**Current value**<br>**(optional)**<br>**119359**<br>**149,801**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Details**<br>Investments<br>~~a~~||||
||**Details**|**Fund to which**<br>**asset belongs**<br>**Cost (optional)**||**Current value**<br>**(optional)**|
|**B4 Assets retained for the**<br>**charity’s own use**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~ee~~||||
|||**Fund to which**<br>**Amount due**||**When due**|
|**Signed by one or two trustees on**<br>**behalf of all the trustees**<br>**B5 Liabilities**<br>CCXX R2 accounts (SS)|**liability relates**<br>**(optional)**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Date of**<br>**approval**<br>**30/09/2024**<br>**Details**<br>**Signature**<br>**Print Name**<br>**Thomas Irving**<br>2<br>08/01/2025<br>~~——=~~||||



CCXX R2 accounts (SS) 

